Literature DB >> 2961353

Clodronate--a new perspective in the treatment of neoplastic bone disease. Proceedings of a meeting. Helsinki.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2961353

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


× No keyword cloud information.
  5 in total

1.  Pamidronate in patients with painful bone metastases, who failed initial treatment with hormones and/or chemotherapy.

Authors:  S Cascinu; V Casadei; E Del Ferro; P Alessandroni; G Catalano
Journal:  Support Care Cancer       Date:  1996-01       Impact factor: 3.603

Review 2.  Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis.

Authors:  N van Rooijen
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

3.  Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?

Authors:  T Klenner; F Wingen; B K Keppler; B Krempien; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1990       Impact factor: 4.553

4.  A tolerability and pharmacokinetic study of a new injectable formulation of disodium clodronate in healthy female volunteers.

Authors:  Gianluigi Poli; Fabrizia Mariotti; Mario Ermanno Corrado; Daniela Acerbi
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2004 Apr-Jun       Impact factor: 2.441

5.  The effect of 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (ADP) on the resorptive function of osteoclasts of known nuclear number.

Authors:  K Piper; A Boyde; S J Jones
Journal:  Calcif Tissue Int       Date:  1994-01       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.